特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
925263

クレアチニンアッセイキット市場 - 成長、傾向、予測(2020年~2025年)

Creatinine Assay Kits Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円
クレアチニンアッセイキット市場 - 成長、傾向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のクレアチニンアッセイキット市場は、2020年から2025年にかけて5.3%のCAGRで拡大すると予測されています。腎障害およびその他の慢性障害の発生率の増加、腎障害に関連する生物医学調査の技術的進歩、および調査開発の取り組みの増加などにより、クレアチニンアッセイキットの需要が高まっています。

当レポートでは、クレアチニンアッセイキットの世界市場を調査し、市場の概要、タイプ、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています 。

目次

第1章 イントロダクション

  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概要
  • 成長要因
  • 抑制要因
  • ファイブフォース分析
    • 新規参入の脅威
    • 消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内での競争

第5章 市場セグメンテーション

  • タイプ別
    • Jaffeキネティックテストキット
    • クレアチニン-PAPテストキット
    • ELISAテストキット
  • サンプルタイプ別
    • 血液/血清
    • 尿
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Merck KGaA
    • Quidel Corporation
    • Cell Biolabs, Inc
    • Genway Biotech
    • Randox Laboratories Ltd
    • ACON Laboratories
    • Nova Biomedical
    • Sysmex India Pvt. Ltd

第7章 市場機会および将来動向

目次
Product Code: 67729

The Creatinine Assay Kits Market is expected to register a CAGR of 5.3% during the forecast period. Creatinine assay kits are used to measure creatinine levels in serum/plasma, urine and other biological samples. Creatinine is a waste product produced by muscles from the breakdown of creatine compound and removed from the body by the kidneys, which filter from the blood and release it into the urine. Creatinine assay is used to analyze the protein metabolism in the body and the levels of creatinine can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and will deflect in the blood test if the kidney is not in the good condition. Creatinine test is performed by using specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes and cancers. According to International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury (AKI) globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. Increasing incidence of renal disorders and other chronic disorders, technological advancements in biomedical research pertaining to kidney disorders and increasing research and development initiatives are the key driving factors in creatinine assay kits market.

Key Market Trends

Jaffe's Kinetic Test Kits Segment is Expected to Hold a Major Market Share in the Creatinine Assay Kits Market

  • Jaffe reaction is a colorimetric method used in clinical chemistry to measure creatinine levels in blood and urine using Jaffe's Kinetic Test Kits.
  • According to the National Kidney Foundation, about 10% of the population worldwide is affected by chronic kidney disease (CKD), and millions die each year with kidney disease.
  • Jaffe's Kinetic Test Kits segment hold a significant market share in the creatinine assay kits market and is anticipated to show a similar trend over the forecast period due to being the conventional method for creatinine measurement and the wide product availability, as well as the cost-effectiveness of these kits.
  • Increasing incidence of renal disorders and other chronic disorders impacting renal function, technological advancements in biomedical research pertaining to kidney disorders are the key driving factors in the Jaffe's kinetic test kits segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global creatinine assay kits market due to increasing incidence of renal disorders and other chronic disorders impacting renal function and technological advancements in biomedical research pertaining to kidney disorders in this region. According to the Centers for Disease Control and Prevention (CDC), approximately 30 million people or 15% of United States adults are estimated to have chronic kidney disease (CKD). chronic kidney disease (CKD) is estimated to be more common in women (16%) than in men (13%). Furthermore, favourable reimbursement policies and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Creatinine Assay Kits Market is highly fragmented competitive and consists of several major players. In terms of market share, majority of the players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation, Cell Biolabs, Inc, Genway Biotech, Randox Laboratories Ltd, ACON Laboratories, Nova Biomedical and Sysmex India Pvt. Ltd.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Renal and Other Chronic Disorders Impacting Renal Function
    • 4.2.2 Technological Advancements in Biomedical Research Pertaining to Kidney Disorders
    • 4.2.3 Increasing Research and Development Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Identification of Novel Renal Dysfunction Biomarkers
    • 4.3.2 Limited Usage of Creatinine Assay Kits in Invitro Diagnostic Device (IVD)
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Jaffe's Kinetic Test kits
    • 5.1.2 Creatinine-PAP Test kits
    • 5.1.3 ELISA Test kits
  • 5.2 By Type of Sample
    • 5.2.1 Blood/Serum
    • 5.2.2 Urine
    • 5.2.3 Other Samples
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Quidel Corporation
    • 6.1.5 Cell Biolabs, Inc
    • 6.1.6 Genway Biotech
    • 6.1.7 Randox Laboratories Ltd
    • 6.1.8 ACON Laboratories
    • 6.1.9 Nova Biomedical
    • 6.1.10 Sysmex India Pvt. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.